IP Library Granted Patent US 7,273,611
Granted Patent B1
US 7,273,611 · App. 09/684,883 · Granted Sep 25, 2007

Proteinase K resistant surface protein of neisseria meningitidis

Assignee: ID Biomedical Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,273,611
App. No.
09/684,883
Granted
Sep 25, 2007
Kind
B1
Abstract

The identification of a highly conserved, immunologically accessible antigen on the surface of Neisseria facilitates treatment, prophylaxis, and diagnosis of Neisseria diseases. This antigen is highly resistant to proteinase K and has an apparent molecular weight of 22 kDa on SDS-PAGE. Specific polynucleotides encoding proteins of this class have been isolated from three Neisseria meningitidis strains and from one Neisseria gonorrhoaea strain. These polynucleotides have been sequenced, and the corresponding full-length amino acid sequences of the encoded polypeptides have been deduced. Recombinant DNA methods for the production of the Neisseria surface protein, and antibodies that bind to this protein are also disclosed.

Claims (5)

1. An isolated polypeptide comprising amino acids 31 to 55 of SEQ ID NO:2.

2. An isolated polypeptide comprising amino acids 51 to 86 of SEQ ID NO:2.

3. An isolated polypeptide comprising amino acids 110 to 140 of SEQ ID NO:2.

4. An isolated polypeptide which is a fragment of SEQ ID NOS:2, 4, 6, or 8, wherein the polypeptide is capable of inducing an immune response to Neisseria.

5. An isolated polypeptide encoded by a polynucleotide that hybridizes under stringent conditions to a polynucleotide that is the complement of SEQ ID NO:1, wherein said stringent conditions comprise hybridization at 42° C. in a solution comprising 50% formamide, and wherein the polypeptide is capable of inducing an immune response to Neisseria.

Assignments (2)
CHANGE OF NAME Recorded Aug 17, 2006
From: BIOCHEM PHARMA INC.
To: SHIRE BIOCHEM INC.
Reel/Frame 018131/0522 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2006
From: SHIRE BIOCHEM INC.
To: ID BIOMEDICAL CORPORATION
Reel/Frame 018131/0564 →
Continuity (3)
Continuation 0891336200
Continuation 0840636200 · Mar 17, 1995
Provisional Application 6000198300 · Aug 4, 1995